ICU Medical Net Income
| ICUI Stock | USD 147.92 0.00 0.00% |
As of the 17th of February 2026, ICU Medical retains the semi deviation of 1.59, and Market Risk Adjusted Performance of 0.0626. ICU Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the entity's future prices.
ICU Medical Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -135.3 M | -128.6 M | |
| Net Loss | -85.4 M | -81.2 M | |
| Net Loss | -105.9 M | -100.6 M | |
| Net Loss | (4.34) | (4.13) | |
| Net Income Per E B T | 2.05 | 2.15 |
ICU | Net Income | Build AI portfolio with ICU Stock |
The Net Income trend for ICU Medical offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether ICU Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest ICU Medical's Net Income Growth Pattern
Below is the plot of the Net Income of ICU Medical over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in ICU Medical financial statement analysis. It represents the amount of money remaining after all of ICU Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is ICU Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICU Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (117.69 M) | 10 Years Trend |
|
Net Income |
| Timeline |
ICU Net Income Regression Statistics
| Arithmetic Mean | 9,806,156 | |
| Coefficient Of Variation | 803.91 | |
| Mean Deviation | 63,691,915 | |
| Median | 40,418,000 | |
| Standard Deviation | 78,832,605 | |
| Sample Variance | 6214.6T | |
| Range | 238.5M | |
| R-Value | (0.59) | |
| Mean Square Error | 4312.8T | |
| R-Squared | 0.35 | |
| Significance | 0.01 | |
| Slope | (9,227,732) | |
| Total Sum of Squares | 99433.3T |
ICU Net Income History
Other Fundumenentals of ICU Medical
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
ICU Medical Net Income component correlations
ICU Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for ICU Medical is extremely important. It helps to project a fair market value of ICU Stock properly, considering its historical fundamentals such as Net Income. Since ICU Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ICU Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ICU Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will ICU introduce new products? Factors like these will boost the valuation of ICU Medical. Market participants price ICU higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Earnings Share (0.32) | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets |
ICU Medical's market price often diverges from its book value, the accounting figure shown on ICU's balance sheet. Smart investors calculate ICU Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since ICU Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ICU Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ICU Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ICU Medical.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in ICU Medical on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding ICU Medical or generate 0.0% return on investment in ICU Medical over 90 days. ICU Medical is related to or competes with Arcutis Biotherapeutics, Dentsply Sirona, Prestige Brand, Haemonetics, LivaNova PLC, Travere Therapeutics, and Heartflow Common. ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion th... More
ICU Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ICU Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ICU Medical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.66 | |||
| Information Ratio | 0.0053 | |||
| Maximum Drawdown | 9.83 | |||
| Value At Risk | (2.90) | |||
| Potential Upside | 4.36 |
ICU Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ICU Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ICU Medical's standard deviation. In reality, there are many statistical measures that can use ICU Medical historical prices to predict the future ICU Medical's volatility.| Risk Adjusted Performance | 0.038 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.0065 | |||
| Treynor Ratio | 0.0526 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ICU Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ICU Medical February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.038 | |||
| Market Risk Adjusted Performance | 0.0626 | |||
| Mean Deviation | 1.51 | |||
| Semi Deviation | 1.59 | |||
| Downside Deviation | 1.66 | |||
| Coefficient Of Variation | 2520.47 | |||
| Standard Deviation | 2.03 | |||
| Variance | 4.13 | |||
| Information Ratio | 0.0053 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.0065 | |||
| Treynor Ratio | 0.0526 | |||
| Maximum Drawdown | 9.83 | |||
| Value At Risk | (2.90) | |||
| Potential Upside | 4.36 | |||
| Downside Variance | 2.74 | |||
| Semi Variance | 2.52 | |||
| Expected Short fall | (1.86) | |||
| Skewness | 0.6821 | |||
| Kurtosis | 0.6599 |
ICU Medical Backtested Returns
ICU Medical is very steady at the moment. ICU Medical holds Efficiency (Sharpe) Ratio of 0.0827, which attests that the company had a 0.0827 % return per unit of volatility over the last 3 months. We have found twenty-seven technical indicators for ICU Medical, which you can use to evaluate the volatility of the entity. Please check out ICU Medical's market risk adjusted performance of 0.0626, and Semi Deviation of 1.59 to validate if the risk estimate we provide is consistent with the expected return of 0.17%. ICU Medical has a performance score of 6 on a scale of 0 to 100. The firm retains a Market Volatility (i.e., Beta) of 1.34, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ICU Medical will likely underperform. ICU Medical currently retains a risk of 2.04%. Please check out ICU Medical potential upside, as well as the relationship between the kurtosis and market facilitation index , to decide if ICU Medical will be following its current trending patterns.
Auto-correlation | 0.24 |
Weak predictability
ICU Medical has weak predictability. Overlapping area represents the amount of predictability between ICU Medical time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ICU Medical price movement. The serial correlation of 0.24 indicates that over 24.0% of current ICU Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.24 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 11.82 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
ICU Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, ICU Medical reported net income of (117.69 Million). This is 134.48% lower than that of the Health Care Equipment & Supplies sector and 218.12% lower than that of the Health Care industry. The net income for all United States stocks is 120.61% higher than that of the company.
ICU Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ICU Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ICU Medical could also be used in its relative valuation, which is a method of valuing ICU Medical by comparing valuation metrics of similar companies.ICU Medical is currently under evaluation in net income category among its peers.
ICU Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, ICU Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ICU Medical's managers, analysts, and investors.Environmental | Governance | Social |
ICU Medical Institutional Holders
Institutional Holdings refers to the ownership stake in ICU Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of ICU Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ICU Medical's value.| Shares | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 538.4 K | Neuberger Berman Group Llc | 2025-06-30 | 519 K | Fmr Inc | 2025-06-30 | 451 K | Millennium Management Llc | 2025-06-30 | 398.3 K | Northern Trust Corp | 2025-06-30 | 388.6 K | Point72 Asset Management, L.p. | 2025-06-30 | 381.5 K | Silvercrest Asset Management Group Llc | 2025-06-30 | 330.2 K | Bank Of America Corp | 2025-06-30 | 310.4 K | Charles Schwab Investment Management Inc | 2025-06-30 | 306.5 K | Blackrock Inc | 2025-06-30 | 3.6 M | Vanguard Group Inc | 2025-06-30 | 2.7 M |
ICU Fundamentals
| Return On Equity | -0.0035 | ||||
| Return On Asset | 0.0192 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 4.64 B | ||||
| Shares Outstanding | 24.69 M | ||||
| Shares Owned By Insiders | 2.87 % | ||||
| Shares Owned By Institutions | 97.13 % | ||||
| Number Of Shares Shorted | 1.14 M | ||||
| Price To Earning | 38.71 X | ||||
| Price To Book | 1.68 X | ||||
| Price To Sales | 1.54 X | ||||
| Revenue | 2.38 B | ||||
| Gross Profit | 846.31 M | ||||
| EBITDA | 42.96 M | ||||
| Net Income | (117.69 M) | ||||
| Cash And Equivalents | 285.59 M | ||||
| Cash Per Share | 11.95 X | ||||
| Total Debt | 1.64 B | ||||
| Debt To Equity | 0.84 % | ||||
| Current Ratio | 2.45 X | ||||
| Book Value Per Share | 86.17 X | ||||
| Cash Flow From Operations | 204.03 M | ||||
| Short Ratio | 4.86 X | ||||
| Earnings Per Share | (0.32) X | ||||
| Price To Earnings To Growth | 1.70 X | ||||
| Target Price | 180.83 | ||||
| Number Of Employees | 15 K | ||||
| Beta | 0.8 | ||||
| Market Capitalization | 3.58 B | ||||
| Total Asset | 4.2 B | ||||
| Retained Earnings | 690.16 M | ||||
| Working Capital | 885.8 M | ||||
| Current Asset | 505.01 M | ||||
| Current Liabilities | 42.62 M | ||||
| Net Asset | 4.2 B |
About ICU Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ICU Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICU Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICU Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is there potential for Health Care Equipment & Supplies market expansion? Will ICU introduce new products? Factors like these will boost the valuation of ICU Medical. Market participants price ICU higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Earnings Share (0.32) | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets |
ICU Medical's market price often diverges from its book value, the accounting figure shown on ICU's balance sheet. Smart investors calculate ICU Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since ICU Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.